Technology Prognosis

tracking technologies before you have to make a decision

AR101 for Treatment of Peanut Allergy

January 3, 2019

AR101 is a proprietary formulation of peanut protein and pharmaceutical-grade ingredients intended for treatment of peanut allergy. AR101 is provided in pull-apart capsules containing gradual escalating doses. AR101 capsules are taken according to a proprietary up-dosing oral immunotherapy regimen known as CODIT (characterized oral desensitization immunotherapy). Patients who respond to CODIT must continue to take a daily maintenance dose of AR101 to sustain desensitization.